| Dr Jennifer Ann Schaal-sampson, AUD | |
|
402 Main St, Allenhurst, NJ 07711-1040 | |
| (732) 517-1200 | |
| (732) 663-0179 |
| Full Name | Dr Jennifer Ann Schaal-sampson |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 24 Years |
| Location | 402 Main St, Allenhurst, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710963954 | NPI | - | NPPES |
| 2369001 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 41YA00039900 (New Jersey) | Secondary |
| 237600000X | Audiologist-hearing Aid Fitter | 25MG00073100 (New Jersey) | Primary |
| Provider Name | Family Hearing Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1700121993 PECOS PAC ID: 0547415713 Enrollment ID: O20130220000204 |
News Archive
In a landmark study, researchers from the Broad Institute and Massachusetts General Hospital reveal a completely new biological mechanism that underlies cancer. By studying brain tumors that carry mutations in the isocitrate dehydrogenase (IDH) genes, the team uncovered some unusual changes in the instructions for how the genome folds up on itself.
Over the past 30 years, a qualified surgeon based in Perth, Australia has been treating cancer patients with a novel form of radio-wave therapy. A news story on the popular Australian television show "A Current Affair", hosted by Ray Martin has sparked great interest from the Australian general public and the wider Australian medical community.
Lobbyists for generic biologic drugmakers are fighting to undercut a provision in the proposed health overhaul that would protect brand-name pharmaceutical companies from lower-cost, generic competition over new products for 12 years, the Associated Press reports. The generic companies have friends in high places: "White House officials and Rep. Henry Waxman, D-Calif., chairman of the House Energy and Commerce Committee, are trying to reduce the curbs against competition to 10 years or less" (Fram, 1/14).
Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Ann Schaal-sampson, AUD 402 Main St, Allenhurst, NJ 07711-1040 Ph: (732) 517-1200 | Dr Jennifer Ann Schaal-sampson, AUD 402 Main St, Allenhurst, NJ 07711-1040 Ph: (732) 517-1200 |
News Archive
In a landmark study, researchers from the Broad Institute and Massachusetts General Hospital reveal a completely new biological mechanism that underlies cancer. By studying brain tumors that carry mutations in the isocitrate dehydrogenase (IDH) genes, the team uncovered some unusual changes in the instructions for how the genome folds up on itself.
Over the past 30 years, a qualified surgeon based in Perth, Australia has been treating cancer patients with a novel form of radio-wave therapy. A news story on the popular Australian television show "A Current Affair", hosted by Ray Martin has sparked great interest from the Australian general public and the wider Australian medical community.
Lobbyists for generic biologic drugmakers are fighting to undercut a provision in the proposed health overhaul that would protect brand-name pharmaceutical companies from lower-cost, generic competition over new products for 12 years, the Associated Press reports. The generic companies have friends in high places: "White House officials and Rep. Henry Waxman, D-Calif., chairman of the House Energy and Commerce Committee, are trying to reduce the curbs against competition to 10 years or less" (Fram, 1/14).
Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.
› Verified 8 days ago